Skip to main content
. Author manuscript; available in PMC: 2023 Jan 13.
Published in final edited form as: Biomark Neuropsychiatry. 2020 May 12;3:100014. doi: 10.1016/j.bionps.2020.100014

Table 2.

Linear Discriminant Analysis Results:

S1 P50 S1 N100 S1 P200 Pre-S2 Low (4–17 Hz) Early/Mid Low (4–17 Hz) Pre-S2 Gamma (33–55Hz) S2 Early
Range: 55–75 ms 76–135 ms 155– 255 ms 435–515 ms 35– 255 ms 455–515 ms 535– 635 ms
Number of time in Jacknife LDA (1000 total) 1000 1000 979 870 1000 1000 999
Omnibus ANOVA F Value 13.51*** 20.86*** 10.99*** 6.75*** 15.92*** 2.86* 4.54**
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
HC (n = 415) 0.073 0.74 −1.263 1.01 1.275 0.95 −0.499 0.460 41.236 3.87 31.601 4.07 17.426 2.92
BDNP (n = 66) 0.698 0.91 −0.966 0.82 1.241 1.07 −0.575 0.471 41.203 3.91 31.681 4.13 19.124 3.14
BDP (n = 171) 0.086 0.80 −1.077 1.01 0.893 0.78 −0.493 0.480 40.211 3.89 31.661 3.94 17.703 3.29
SAD (n = 201) 0.328 0.75 −0.684 0.81 0.968 0.78 −0.458 0.511 39.376 3.88 32.559 4.01 17.878 2.98
SZ (n = 225) 0.044 0.75 −0.677 0.87 0.911 0.73 −0.316 0.519 39.049 3.71 32.407 4.29 17.668 3.25
Effect Sizes (Glass Delta)
BDNP 0.84 0.29 −0.04 −0.17 −0.01 0.02 0.58
BDP 0.02 0.18 −0.40 0.01 −0.26 0.01 0.09
SAD 0.34 0.57 −0.32 0.09 −0.48 0.24 0.16
SZ −0.04 0.58 −0.38 0.40 −0.57 0.20 0.08
Tukey’s B [BDNP]> [SAD]> [BDP/ HC/ SZ] [HC/ BDNP]> [BDNP/ BDP]> [SAD/ SZ] [HC/ BDNP]> [SAD /SZ/ BDP] [SZ] > [SAD/ BDP/ HC/ BDNP] [HC/ BDNP/ BDP] > [BDP/ SAD]> [SAD/ SZ] n.s. [BDNP]> [SAD/ BDP/ SZ/ HC]

Note: HC, Healthy Subjects; SZ, Probands with schizophrenia; BDP, Probands with bipolar disorder I with a history of psychotic symptoms; SAD, Probands with